184 related articles for article (PubMed ID: 8103456)
1. Expression of P-glycoprotein and multidrug resistance in renal cell carcinoma.
Naito S; Sakamoto N; Kotoh S; Goto K; Matsumoto T; Kumazawa J
Eur Urol; 1993; 24(1):156-60. PubMed ID: 8103456
[TBL] [Abstract][Full Text] [Related]
2. Correlation between the expression of P-glycoprotein and multidrug-resistant phenotype in transitional cell carcinoma of the urinary tract.
Naito S; Sakamoto N; Kotoh S; Goto K; Matsumoto T; Kumazawa J
Eur Urol; 1992; 22(2):158-62. PubMed ID: 1362155
[TBL] [Abstract][Full Text] [Related]
3. Detection of drug resistance and P-glycoprotein in human renal cell carcinomas.
Bak M; Efferth T; Mickisch G; Mattern J; Volm M
Eur Urol; 1990; 17(1):72-5. PubMed ID: 1969346
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms and modulation of multidrug resistance in primary human renal cell carcinoma.
Mickisch GH; Roehrich K; Koessig J; Forster S; Tschada RK; Alken PM
J Urol; 1990 Sep; 144(3):755-9. PubMed ID: 1974934
[TBL] [Abstract][Full Text] [Related]
5. The expression of mdr-1-related gp-170 and its correlation with anthracycline resistance in renal cell carcinoma cell lines and multidrug-resistant sublines.
Yu DS; Chang SY; Ma CP
Br J Urol; 1998 Oct; 82(4):544-7. PubMed ID: 9806185
[TBL] [Abstract][Full Text] [Related]
6. Verapamil enhances doxorubicin activity in cultured human renal carcinoma cells.
Lai T; Collins CM; Hall P; Morgan AP; Smith PJ; Stonebridge BR; Symes MO
Eur J Cancer; 1993; 29A(3):378-83. PubMed ID: 8104443
[TBL] [Abstract][Full Text] [Related]
7. Role of the MDR-1-encoded multiple drug resistance phenotype in prostate cancer cell lines.
Theyer G; Schirmböck M; Thalhammer T; Sherwood ER; Baumgartner G; Hamilton G
J Urol; 1993 Nov; 150(5 Pt 1):1544-7. PubMed ID: 8105110
[TBL] [Abstract][Full Text] [Related]
8. New potent verapamil derivatives that reverse multidrug resistance in human renal carcinoma cells and in transgenic mice expressing the human MDR1 gene.
Mickisch GH; Merlino GT; Aiken PM; Gottesman MM; Pastan I
J Urol; 1991 Aug; 146(2):447-53. PubMed ID: 1677434
[TBL] [Abstract][Full Text] [Related]
9. Elacridar enhances the cytotoxic effects of sunitinib and prevents multidrug resistance in renal carcinoma cells.
Sato H; Siddig S; Uzu M; Suzuki S; Nomura Y; Kashiba T; Gushimiyagi K; Sekine Y; Uehara T; Arano Y; Yamaura K; Ueno K
Eur J Pharmacol; 2015 Jan; 746():258-66. PubMed ID: 25455500
[TBL] [Abstract][Full Text] [Related]
10. Expression of the multidrug transporter, P-glycoprotein, in renal and transitional cell carcinomas.
Nishiyama K; Shirahama T; Yoshimura A; Sumizawa T; Furukawa T; Ichikawa-Haraguchi M; Akiyama S; Ohi Y
Cancer; 1993 Jun; 71(11):3611-9. PubMed ID: 8098269
[TBL] [Abstract][Full Text] [Related]
11. Circumvention of multidrug resistance mediated by P-170 glycoprotein using calcium antagonists in primary human renal cell carcinoma.
Mickisch GH; Kössig J; Tschada RK; Keilhauer G; Schlick E; Alken PM
Urol Int; 1991; 47(3):118-25. PubMed ID: 1685271
[TBL] [Abstract][Full Text] [Related]
12. Constitutive expression of functional P-glycoprotein in rat hepatoma cells.
Fardel O; Loyer P; Lecureur V; Glaise D; Guillouzo A
Eur J Biochem; 1994 Jan; 219(1-2):521-8. PubMed ID: 7905826
[TBL] [Abstract][Full Text] [Related]
13. Circumvention of multi-drug resistance in human kidney and kidney carcinoma in vitro.
Volm M; Pommerenke EW; Efferth T; Löhrke H; Mattern J
Cancer; 1991 May; 67(10):2484-9. PubMed ID: 1673084
[TBL] [Abstract][Full Text] [Related]
14. Expression of multidrug resistance gene product (P-glycoprotein) in transitional cell carcinomas of the upper urinary tract.
Shinohara N; Nonomura K; Takakura F; Hamada M; Grossman HB; Koyanagi T
Eur Urol; 1994; 26(4):327-33. PubMed ID: 7713132
[TBL] [Abstract][Full Text] [Related]
15. [Enhancement of cytotoxic effect of anticancer agents of renal cell carcinoma].
Okano M; Kawamoto S; Nezasa S; Tamaki M; Ehara H; Yamada S; Deguchi T; Kawada Y
Nihon Hinyokika Gakkai Zasshi; 1996 Aug; 87(8):1041-7. PubMed ID: 8831211
[TBL] [Abstract][Full Text] [Related]
16. Reversal of inherent multidrug-resistance in primary human renal cell carcinoma cell cultures by S 9788.
Efferth T; Dunn TA; Berlion M; Langenbahn H; Pommerenke EW; Volm M
Anticancer Res; 1993; 13(4):905-8. PubMed ID: 8102519
[TBL] [Abstract][Full Text] [Related]
17. Low external pH and osmotic shock increase the expression of human MDR protein.
Wei LY; Roepe PD
Biochemistry; 1994 Jun; 33(23):7229-38. PubMed ID: 7911681
[TBL] [Abstract][Full Text] [Related]
18. Influence of vinblastine on DNA parameters and multidrug resistance in renal cell carcinoma in vitro.
Domagk D; Blüthner-Hässler C; Kugler A; Kallerhoff M; Ringert RH
Urol Res; 1998; 26(2):123-7. PubMed ID: 9631945
[TBL] [Abstract][Full Text] [Related]
19. Organ-specific modulation of steady-state mdr gene expression and drug resistance in murine colon cancer cells.
Dong Z; Radinsky R; Fan D; Tsan R; Bucana CD; Wilmanns C; Fidler IJ
J Natl Cancer Inst; 1994 Jun; 86(12):913-20. PubMed ID: 7910854
[TBL] [Abstract][Full Text] [Related]
20. P-glycoprotein expression and schedule dependence of adriamycin cytotoxicity in human colon carcinoma cell lines.
Lai GM; Chen YN; Mickley LA; Fojo AT; Bates SE
Int J Cancer; 1991 Nov; 49(5):696-703. PubMed ID: 1682280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
